Beta-Crosslaps Antibody (Polyclonal)

<strong>Beta-Crosslaps Antibody</strong>_x000D_ <strong>Catalog number:</strong> B2010381_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 50 ug_x000D_ <strong>Molecular Weight or Concentration:</strong> 150 kDa_x000D_ <strong>Supplied as:</strong> Liquid_x000D_ <strong>Appearance:</strong> Clear Solution_x000D_ <strong>Applications:</strong> a rabbit polyclonal antibody specific to Beta-Crosslaps (bCTx). This antibody has been purified by antigen-specific affinity chromatography, followed by Protein A affinity chromatography._x000D_ <strong>Storage:</strong> -20C_x000D_ <strong>Keywords:</strong> Beta-Crosslaps, bCTx, Beta-CTx, Beta CrossLaps_x000D_ <strong>Grade:</strong> Biotechnology grade. All solid components are highly pure (minimum 95%). All solutions are made with Type I ultrapure water (resistivity &gt;18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1: Coppolino G, Lucisano G, Rivoli L, Simeoni M, De Paola L, Timpano R, Palmieri_x000D_ C, Fuiano G. Serum β-crosslaps as predictor of long-term parathyroid hormone_x000D_ levels in hemodialysis patients. J Investig Med. 2015 Mar;63(3):539-44._x000D_ _x000D_ 2: Herrmann M, Pape G, Herrmann W. Measurement of serum beta-crosslaps is_x000D_ influenced by proteolytic conditions. Clin Chem Lab Med. 2002 Aug;40(8):790-4._x000D_ _x000D_ 3: Vallet S, Hoyle NR, Kyle RA, Podar K, Pecherstorfer M. A role for bone_x000D_ turnover markers β-CrossLaps (CTX) and amino-terminal propeptide of type I_x000D_ collagen (PINP) as potential indicators for disease progression from MGUS to_x000D_ multiple myeloma. Leuk Lymphoma. 2018 Oct;59(10):2431-2438._x000D_ _x000D_ 4: Okabe R, Nakatsuka K, Inaba M, Miki T, Naka H, Masaki H, Moriguchi A,_x000D_ Nishizawa Y. Clinical evaluation of the Elecsys beta-CrossLaps serum assay, a_x000D_ new assay for degradation products of type I collagen C-tlopeptides. Clin Chem._x000D_ 2001 Aug;47(8):1410-4._x000D_ _x000D_ 5: Schmidt-Gayk H, Spanuth E, Kötting J, Bartl R, Felsenberg D, Pfeilschifter J,_x000D_ Raue F, Roth HJ. Performance evaluation of automated assays for beta-CrossLaps,_x000D_ N-MID-Osteocalcin and intact parathyroid hormone (BIOROSE Multicenter Study)._x000D_ Clin Chem Lab Med. 2004 Jan;42(1):90-5._x000D_ _x000D_ 6: Jean G, Lafage-Proust MH, Souberbielle JC, Lechevallier S, Deleaval P,_x000D_ Lorriaux C, Hurot JM, Mayor B, Mehdi M, Chazot C. Severe secondary_x000D_ hyperparathyroidism in patients on haemodialysis is associated with a high_x000D_ initial serum parathyroid hormone and beta-CrossLaps level: Results from an_x000D_ incident cohort. PLoS One. 2018 Jun 18;13(6):e0199140._x000D_ <a href="https://pubmed.ncbi.nlm.nih.gov/17889845/">7: Salem AM, Zohny SF, Abd El-Wahab MM, Hamdy R. Predictive value of osteocalcin_x000D_ and beta-CrossLaps in metastatic breast cancer. Clin Biochem. 2007_x000D_ Nov;40(16-17):1201-8.</a>_x000D_ _x000D_ <strong>Products Related to Beta-Crosslaps Antibody </strong> <a href="https://moleculardepot.com/product-category/Antibodies/">: Antibodies</a>